Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4QID2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.450 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.451 |
CLV_PCSK_PC1ET2_1 | 193 | 195 | PF00082 | 0.632 |
CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.619 |
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.417 |
DEG_MDM2_SWIB_1 | 124 | 131 | PF02201 | 0.362 |
DOC_MAPK_FxFP_2 | 67 | 70 | PF00069 | 0.619 |
DOC_MAPK_MEF2A_6 | 103 | 110 | PF00069 | 0.617 |
DOC_MAPK_NFAT4_5 | 103 | 111 | PF00069 | 0.615 |
DOC_PP4_FxxP_1 | 67 | 70 | PF00568 | 0.629 |
DOC_USP7_MATH_1 | 208 | 212 | PF00917 | 0.494 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.714 |
DOC_USP7_UBL2_3 | 189 | 193 | PF12436 | 0.427 |
DOC_WW_Pin1_4 | 18 | 23 | PF00397 | 0.693 |
LIG_14-3-3_CanoR_1 | 107 | 117 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 23 | 29 | PF00244 | 0.667 |
LIG_14-3-3_CanoR_1 | 4 | 12 | PF00244 | 0.603 |
LIG_14-3-3_CanoR_1 | 87 | 93 | PF00244 | 0.617 |
LIG_APCC_ABBA_1 | 60 | 65 | PF00400 | 0.613 |
LIG_deltaCOP1_diTrp_1 | 141 | 147 | PF00928 | 0.416 |
LIG_deltaCOP1_diTrp_1 | 183 | 188 | PF00928 | 0.430 |
LIG_deltaCOP1_diTrp_1 | 209 | 220 | PF00928 | 0.449 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.472 |
LIG_FHA_1 | 198 | 204 | PF00498 | 0.511 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.625 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.612 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.597 |
LIG_KLC1_Yacidic_2 | 163 | 168 | PF13176 | 0.400 |
LIG_LIR_Apic_2 | 168 | 173 | PF02991 | 0.399 |
LIG_LIR_Apic_2 | 199 | 204 | PF02991 | 0.425 |
LIG_LIR_Apic_2 | 65 | 70 | PF02991 | 0.628 |
LIG_LIR_Gen_1 | 141 | 152 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 180 | 190 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 127 | 131 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 141 | 147 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.446 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.727 |
LIG_LIR_Nem_3 | 65 | 69 | PF02991 | 0.618 |
LIG_MYND_3 | 157 | 161 | PF01753 | 0.422 |
LIG_PDZ_Class_1 | 215 | 220 | PF00595 | 0.489 |
LIG_Pex14_1 | 117 | 121 | PF04695 | 0.393 |
LIG_Pex14_2 | 116 | 120 | PF04695 | 0.360 |
LIG_Pex14_2 | 121 | 125 | PF04695 | 0.367 |
LIG_Pex14_2 | 74 | 78 | PF04695 | 0.708 |
LIG_SH2_STAP1 | 182 | 186 | PF00017 | 0.439 |
LIG_SH2_STAT3 | 166 | 169 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.610 |
LIG_SH3_3 | 152 | 158 | PF00018 | 0.393 |
LIG_SH3_3 | 51 | 57 | PF00018 | 0.671 |
LIG_SH3_3 | 73 | 79 | PF00018 | 0.623 |
LIG_SH3_4 | 189 | 196 | PF00018 | 0.426 |
LIG_TRAF2_1 | 81 | 84 | PF00917 | 0.605 |
LIG_TRAF2_2 | 204 | 209 | PF00917 | 0.421 |
MOD_CDK_SPK_2 | 18 | 23 | PF00069 | 0.693 |
MOD_CK1_1 | 112 | 118 | PF00069 | 0.350 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.220 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.716 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.615 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.719 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.614 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.600 |
MOD_CMANNOS | 117 | 120 | PF00535 | 0.306 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.508 |
MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.500 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.506 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.734 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.741 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.609 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.611 |
MOD_N-GLC_1 | 108 | 113 | PF02516 | 0.387 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.604 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.375 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.589 |
MOD_PK_1 | 82 | 88 | PF00069 | 0.611 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.723 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.589 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.615 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.611 |
MOD_Plk_1 | 89 | 95 | PF00069 | 0.613 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.466 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.335 |
MOD_ProDKin_1 | 18 | 24 | PF00069 | 0.695 |
MOD_SUMO_rev_2 | 31 | 36 | PF00179 | 0.672 |
MOD_SUMO_rev_2 | 72 | 79 | PF00179 | 0.631 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.383 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.427 |
TRG_ER_diArg_1 | 3 | 5 | PF00400 | 0.652 |
TRG_ER_diArg_1 | 36 | 39 | PF00400 | 0.765 |
TRG_PTS1 | 217 | 220 | PF00515 | 0.458 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P933 | Leptomonas seymouri | 81% | 99% |
A0A0S4IVJ7 | Bodo saltans | 66% | 100% |
A0A1X0NP20 | Trypanosomatidae | 72% | 100% |
A0A3S5H645 | Leishmania donovani | 96% | 100% |
A4H5A9 | Leishmania braziliensis | 89% | 100% |
A4HTI8 | Leishmania infantum | 96% | 100% |
C9ZPJ6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 100% |
E9AMB6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
V5DHY0 | Trypanosoma cruzi | 72% | 100% |